Fufang shenhua tablet, astragali radix and its active component astragaloside IV: Research progress on anti-inflammatory and immunomodulatory mechanisms in the kidney

Background: Given the limited treatment options available for kidney disease, a significant number of patients turn to alternative therapies, including traditional Chinese medicine. Among these therapies, the Fufang Shenhua tablet (SHT) has garnered attention for its effectiveness in addressing the...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Run, Shi, Chunru, Wei, Cuiting, Wang, Chao, Du, Hongjian, Hong, Quan, Chen, Xiangmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113559/
https://www.ncbi.nlm.nih.gov/pubmed/37089929
http://dx.doi.org/10.3389/fphar.2023.1131635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113559/
https://www.ncbi.nlm.nih.gov/pubmed/37089929
http://dx.doi.org/10.3389/fphar.2023.1131635

Ejemplares similares